PreludeDx and Quanterix announce breast cancer test validation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. APGE
6. ABBV
7. DFTX
8. RGNX
9. GOOGL
10. LCO

Go back to PreludeDx and Quanterix announce breast cancer test validation
(NASDAQ: QTRX) Delayed: 3.24 -0.15 (4.42%)
Previous Close $3.39    52 Week High $ 
Open $3.40    52 Week Low $ 
Day High $3.50    P/E N/A 
Day Low $3.21    EPS $ 
Volume 208,112